Development of rheumatoid arthritis medications using SEVDP vector that express anti-CD81 antibody

○Tsutomu Yamasaki

[26P2-am1-107] Development of rheumatoid arthritis medications using SEVDP vector that express anti-CD81 antibody

○Tsutomu Yamasaki¹, Yuta Fujii², Yuji Arai², Shuji Nakagawa², Kenji Takahashi², Masato Nakanishi³, Tohru Nakanishi^1,4 (1. Sch. Pharm., Shujitsu Univ., 2. Grad. Sch. Medi. Sci., Kyoto Prefectural Univ. of Med., 3. TOKIWA-Bio Inc., 4. Grad. Sch. Pharm., Shujitsu Univ.)

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Presentation information

[26P2-am1] Clinical pharmaceutical sciences/Others

[26P2-am1-107] Development of rheumatoid arthritis medications using SEVDP vector that express anti-CD81 antibody

Password